{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:04:56Z","timestamp":1772136296460,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"VHS Medical Center","award":["VHSMC 21041"],"award-info":[{"award-number":["VHSMC 21041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We evaluated the predictive value of dynamic blood flow scintigraphy with\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-HDP (hydroxymethylene diphosphonate) for therapeutic response in patients with Raynaud\u2019s phenomenon (RP). Eighty patients who underwent dynamic blood flow scintigraphy using the one-hand chilling method were enrolled. We analyzed the quantitative variables as the ratio of chilled fingers to ambient fingers (CA\n                    <jats:sub>finger<\/jats:sub>\n                    ), that of the chilled hand to ambient hand (CA\n                    <jats:sub>hand<\/jats:sub>\n                    ), and that of chilled fingers to ambient palm (FPR) (CA\n                    <jats:sub>FPR<\/jats:sub>\n                    ) at 15 and 30\u00a0s after\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-HDP bolus injection. Total cumulative radioactivity counts for 180\u00a0s were obtained. We evaluated the clinical utility of these quantitative parameters with other clinical variables, including RP severity, therapeutic compliance, types of RP, and scintigraphic interpretation of findings in patients with RP. Fifty-two patients showed poor therapeutic response. There were significant differences between good- and poor-therapeutic responder groups in RP intensity (p\u2009=\u20090.003), CA\n                    <jats:sub>finger15s<\/jats:sub>\n                    (p\u2009=\u20090.008), CA\n                    <jats:sub>finger30s<\/jats:sub>\n                    (p\u2009=\u20090.002), CA\n                    <jats:sub>finger180s<\/jats:sub>\n                    (p\u2009=\u20090.011), CA\n                    <jats:sub>hand15s<\/jats:sub>\n                    (p\u2009=\u20090.008), CA\n                    <jats:sub>hand30s<\/jats:sub>\n                    (p\u2009=\u20090.007), CA\n                    <jats:sub>hand180s<\/jats:sub>\n                    (p\u2009=\u20090.017), CA\n                    <jats:sub>FPR30s<\/jats:sub>\n                    (p\u2009=\u20090.004), and CA\n                    <jats:sub>FPR180s<\/jats:sub>\n                    (p\u2009=\u20090.002). After multivariate logistic regression analysis, only CA\n                    <jats:sub>finger30s<\/jats:sub>\n                    (p\u2009=\u20090.002) had an independent predictive value of the therapeutic response.\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-HDP dynamic blood flow scintigraphy could be helpful in predicting the therapeutic response in patients with RP.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-47197-3","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T08:01:45Z","timestamp":1699862505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic blood flow imaging with 99mTc-hydroxymethylene diphosphonate as a therapeutic response marker in patients with Raynaud\u2019s phenomenon"],"prefix":"10.1038","volume":"13","author":[{"given":"Jang","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miju","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"47197_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1024\/0301-1526\/a000426","volume":"44","author":"B Linnemann","year":"2015","unstructured":"Linnemann, B. & Erbe, M. Raynauds phenomenon\u2014assessment and differential diagnoses. Vasa. 44, 166\u2013177 (2015).","journal-title":"Vasa."},{"key":"47197_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.autrev.2013.12.001","volume":"13","author":"M Prete","year":"2014","unstructured":"Prete, M., Fatone, M. C., Favoino, E. & Perosa, F. Raynaud\u2019s phenomenon: From molecular pathogenesis to therapy. Autoimmun. Rev. 13, 655\u2013667 (2014).","journal-title":"Autoimmun. Rev."},{"key":"47197_CR3","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.17219\/acem\/75618","volume":"27","author":"I Gosk-Bierska","year":"2018","unstructured":"Gosk-Bierska, I. et al. Analysis of peripheral nerve and autonomic nervous system function and the stage of microangiography in patients with secondary Raynaud\u2019s phenomenon in the course of connective tissue diseases. Adv. Clin. Exp. Med. 27, 1587\u20131592 (2018).","journal-title":"Adv. Clin. Exp. Med."},{"key":"47197_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.5830\/CVJA-2015-032","volume":"26","author":"K Karabacak","year":"2015","unstructured":"Karabacak, K. et al. Autonomic imbalance assessed by time-domain heart rate variability indices in primary Raynaud\u2019s phenomenon. Cardiovasc. J. Afr. 26, 214\u2013216 (2015).","journal-title":"Cardiovasc. J. Afr."},{"key":"47197_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMra1507638","volume":"375","author":"FM Wigley","year":"2016","unstructured":"Wigley, F. M. & Flavahan, N. A. Raynaud\u2019s phenomenon. N. Engl. J. Med. 375, 556\u2013565 (2016).","journal-title":"N. Engl. J. Med."},{"key":"47197_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4081\/reumatismo.2013.691","volume":"65","author":"S Parisi","year":"2014","unstructured":"Parisi, S. et al. Efficacy of bosentan in the treatment of Raynaud\u2019s phenomenon in patients with systemic sclerosis never treated with prostanoids. Reumatismo. 65, 286\u2013291 (2014).","journal-title":"Reumatismo."},{"key":"47197_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1024\/0301-1526\/a000526","volume":"45","author":"B Linnemann","year":"2016","unstructured":"Linnemann, B. & Erbe, M. Raynaud\u2019s phenomenon and digital ischaemia\u2014pharmacologic approach and alternative treatment options. Vasa. 45, 201\u2013212 (2016).","journal-title":"Vasa."},{"key":"47197_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2014.01.020","volume":"48\u201349","author":"E Maverakis","year":"2014","unstructured":"Maverakis, E. et al. International consensus criteria for the diagnosis of Raynaud\u2019s phenomenon. J. Autoimmun. 48\u201349, 60\u201365 (2014).","journal-title":"J. Autoimmun."},{"key":"47197_CR9","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1088\/0967-3334\/35\/7\/R91","volume":"35","author":"J Allen","year":"2014","unstructured":"Allen, J. & Howell, K. Microvascular imaging: techniques and opportunities for clinical physiological measurements. Physiol. Meas. 35, R91\u2013R141 (2014).","journal-title":"Physiol. Meas."},{"key":"47197_CR10","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/rheumatology\/ket153","volume":"52","author":"M Cutolo","year":"2013","unstructured":"Cutolo, M. & Smith, V. State of the art on nailfold capillaroscopy: A reliable diagnostic tool and putative biomarker in rheumatology?. Rheumatology (Oxford). 52, 1933\u20131940 (2013).","journal-title":"Rheumatology (Oxford)."},{"key":"47197_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12933-016-0487-1","volume":"16","author":"D Fuchs","year":"2017","unstructured":"Fuchs, D., Dupon, P. P., Schaap, L. A. & Draijer, R. The association between diabetes and dermal microvascular dysfunction non-invasively assessed by laser Doppler with local thermal hyperemia: A systematic review with meta-analysis. Cardiovasc. Diabetol. 16, 11 (2017).","journal-title":"Cardiovasc. Diabetol."},{"key":"47197_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3899\/jrheum.141437","volume":"42","author":"JD Pauling","year":"2015","unstructured":"Pauling, J. D., Shipley, J. A., Hart, D. J., McGrogan, A. & McHugh, N. J. Use of laser speckle contrast imaging to assess digital microvascular function in primary Raynaud phenomenon and systemic sclerosis: A comparison using the Raynaud condition score diary. J. Rheumatol. 42, 1163\u20131168 (2015).","journal-title":"J. Rheumatol."},{"key":"47197_CR13","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3899\/jrheum.080988","volume":"36","author":"SR Kwon","year":"2009","unstructured":"Kwon, S. R., Lim, M. J., Park, S. G., Hyun, I. Y. & Park, W. Diagnosis of Raynaud\u2019s phenomenon by (99m)Tc-hydroxymethylene diphosphonate digital blood flow scintigraphy after one-hand chilling. J. Rheumatol. 36, 1663\u20131670 (2009).","journal-title":"J. Rheumatol."},{"key":"47197_CR14","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/MNM.0b013e3283567492","volume":"33","author":"JW Lee","year":"2012","unstructured":"Lee, J. W., Jeong, W. S., Lee, S. M. & Kim, J. Comparison of the diagnostic performances of two protocols of hand perfusion scintigraphy for Raynaud\u2019s phenomenon. Nucl. Med. Commun. 33, 1032\u20131038 (2012).","journal-title":"Nucl. Med. Commun."},{"key":"47197_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s13139-013-0215-7","volume":"47","author":"A Chong","year":"2013","unstructured":"Chong, A., Ha, J. M., Song, H. C., Kim, J. & Choi, S. J. Conversion to paradoxical finding on technetium-99m-labeled RBC scintigraphy after treatment for secondary Radynaud\u2019s phenomenon. Nucl. Med. Mol. Imaging. 47, 278\u2013280 (2013).","journal-title":"Nucl. Med. Mol. Imaging."},{"key":"47197_CR16","first-page":"138","volume":"35","author":"KA Lee","year":"2017","unstructured":"Lee, K. A., Chung, H. W., Lee, S. H. & Kim, H. R. The use of hand perfusion scintigraphy to assess Raynaud\u2019s phenomenon associated with hand-arm vibration syndrome. Clin. Exp. Rheumatol. 35, 138\u2013143 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"47197_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s13139-020-00671-6","volume":"54","author":"A Chong","year":"2020","unstructured":"Chong, A. Perfusion scintigraphy for the evaluation of patients with Raynaud\u2019s phenomenon. Nucl. Med. Mol. Imaging. 54, 269\u2013273 (2020).","journal-title":"Nucl. Med. Mol. Imaging."},{"key":"47197_CR18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.apmr.2011.01.022","volume":"92","author":"BM Huisstede","year":"2011","unstructured":"Huisstede, B. M. et al. Effectiveness of interventions for secondary Raynaud\u2019s phenomenon: A systematic review. Arch. Phys. Med. Rehabil. 92, 1166\u20131180 (2011).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"47197_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/914692","volume":"2015","author":"KD Lensen","year":"2015","unstructured":"Lensen, K. D. et al. Large-vessel vasculitis: Interobserver agreement and diagnostic accuracy of 18F-FDG PET\/CT. Biomed. Res. Int. 2015, 914692 (2015).","journal-title":"Biomed. Res. Int."},{"key":"47197_CR20","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.jvs.2013.03.012","volume":"57","author":"GJ Landry","year":"2013","unstructured":"Landry, G. J. Current medical and surgical management of Raynaud\u2019s syndrome. J. Vasc. Surg. 57, 1710\u20131716 (2013).","journal-title":"J. Vasc. Surg."},{"key":"47197_CR21","volume":"14","author":"I Nawaz","year":"2022","unstructured":"Nawaz, I., Nawaz, Y., Nawaz, E., Manan, M. R. & Mahmood, A. Raynaud\u2019s phenomenon: Reviewing the pathophysiology and management strategies. Cureus. 14, e21681 (2022).","journal-title":"Cureus."},{"key":"47197_CR22","doi-asserted-by":"crossref","unstructured":"Rirash, F., et al. Calcium channel blockers for primary and secondary Raynaud\u2019s phenomenon. Cochrane Database Syst. Rev. 12, CD000467 (2017).","DOI":"10.1002\/14651858.CD000467.pub2"},{"key":"47197_CR23","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00296-016-3584-2","volume":"36","author":"S Pavlov-Dolijanovic","year":"2016","unstructured":"Pavlov-Dolijanovic, S. et al. Diagnosis of Raynaud\u2019s phenomenon by 99mTc-pertechnetate hand perfusion scintigraphy: a pilot study. Rheumatol. Int. 36, 1683\u20131688 (2016).","journal-title":"Rheumatol. Int."},{"key":"47197_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s41927-022-00272-0","volume":"6","author":"A Stjernbrandt","year":"2022","unstructured":"Stjernbrandt, A. et al. Incidence, remission, and persistence of Raynaud\u2019s phenomenon in the general population of northern Sweden: A prospective study. BMC Rheumatol. 6, 41 (2022).","journal-title":"BMC Rheumatol."},{"key":"47197_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/1759720X17740074","volume":"9","author":"AL Herrick","year":"2017","unstructured":"Herrick, A. L. Evidence-based management of Raynaud\u2019s phenomenon. Ther. Adv. Musculoskelet. Dis. 9, 317\u2013329 (2017).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"47197_CR26","first-page":"123","volume":"113","author":"KK Temprano","year":"2016","unstructured":"Temprano, K. K. A review of Raynaud\u2019s disease. Mol. Med. 113, 123\u2013126 (2016).","journal-title":"Mol. Med."},{"key":"47197_CR27","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00296-006-0121-8","volume":"26","author":"Z Csiki","year":"2006","unstructured":"Csiki, Z. et al. Raynaud\u2019s syndrome: comparison of late and early onset forms using hand perfusion scintigraphy. Rheumatol. Int. 26, 1014\u20131018 (2006).","journal-title":"Rheumatol. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47197-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T08:05:18Z","timestamp":1699862718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47197-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47197"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47197-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2934863\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19751"}}